Pre-treatment anaemia (Hb <10.0 g/dl) however, was observed in 10 subjects (4/51 in ANQ and 6/49 in CQ+SP), which improved upon treatment except in two patients (one in each treatment group). Here, GSTM1 is linked to anemia.